US Company On Board with England’s Genome Sequencing Project

Reuters reports that a US company that uses artificial intelligence to discover new drugs and diagnostics is to work with England’s national genomics project to mine DNA and health data for potential drug targets. Berg (Boston, MA), co-founded in 2006 by billionaire Carl Berg, uses artificial intelligence “to look at patterns in the data to find areas in the biology that are fingerprints of that disease.” The company uses an artificial intelligence supercomputer platform to look inside cells and study the proteins, the lipids that form cell membranes and govern cell communication and the way cells metabolize energy. Genomics England’s 100,000 Genomes Project aims to accelerate development of new diagnostics and treatments through a year-long industry trial. It will sequence 100,000 genomes from around 70,000 NHS patients with a rare…

Link to Full Article: US Company On Board with England’s Genome Sequencing Project

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!